Reported 5-10% loss: Fda approval for the weight loss pills, Qsymia (by vivus, inc.) and Belviq (lorcaserin) (by arena pharmaceuticals) came recently. Qsymia reportedly helped patients on average lose at least 10 percent of their weight after a year of treatment in clinical trials - compared to the average 5 percent weight loss seen in clinical trials of belviq (lorcaserin). That means the 222-pound person might be 200-pounds after a year.
Answered 6/30/2014
5.7k views
4 doctors weighed in across 2 answers
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
10 doctors weighed in across 2 answers
4 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question